MARC hosted the inaugural workshop of the National Pharmacomicrobiomics Alliance, a project funded by the Egyptian Academy of Scientific Research and Technology (ASRT) under the JESOR program. Led by MARC, the alliance brings together scientists from the Faculty of Pharmacy at Cairo University, Future University in Egypt, and Children’s Cancer Hospital Egypt 57357, with the aim of advancing pharmacomicrobiomics in Egypt, training young scientists, and promoting technology exchange with US-Egyptian experts. The workshop welcomed prominent leaders in higher education and scientific research, along with senior and junior microbiome specialists from across Egypt. The project’s US-Egyptian partner, Dr. Mohamed Aboudonia of Princeton University and a pioneer in microbiome research, delivered the keynote presentation, highlighting cutting-edge technologies developed in his laboratory and outlining opportunities and challenges for the Egyptian team. The event opened with remarks by MARC CEO Dr. George M. Ragheb, followed by an introduction to the alliance and the field of pharmacomicrobiomics by the project’s principal investigator, Dr. Ramy K. Aziz. Dr. Mohamed Nagy, a leading expert in pharmacogenetics and alliance member, also spoke about the importance of pharmacogenomic testing and its relevance to the emerging field of pharmacomicrobiomics. During the workshop, Dr. Sara Zahran, the workshop coordinator, presented the project’s progress over its first six months, including the contributions of graduate and undergraduate students in updating the drug-microbiome database and identifying new drug-modifying enzyme variants. Students also presented their recent work and received expert feedback, reflecting the alliance’s strong focus on research capacity building and scientific training in Egypt.